Serina Therapeutics (SER) Leases (2019 - 2025)
Serina Therapeutics' Leases history spans 5 years, with the latest figure at $312000.0 for Q3 2025.
- For Q3 2025, Leases fell 38.7% year-over-year to $312000.0; the TTM value through Sep 2025 reached $312000.0, down 38.7%, while the annual FY2024 figure was $461000.0, 30.78% down from the prior year.
- Leases for Q3 2025 was $312000.0 at Serina Therapeutics, down from $362000.0 in the prior quarter.
- Across five years, Leases topped out at $666000.0 in Q4 2023 and bottomed at $81000.0 in Q1 2025.
- The 3-year median for Leases is $337000.0 (2025), against an average of $339625.0.
- The largest YoY upside for Leases was 122.09% in 2025 against a maximum downside of 50.31% in 2025.
- A 3-year view of Leases shows it stood at $666000.0 in 2023, then tumbled by 30.78% to $461000.0 in 2024, then plummeted by 32.32% to $312000.0 in 2025.
- Per Business Quant, the three most recent readings for SER's Leases are $312000.0 (Q3 2025), $362000.0 (Q2 2025), and $81000.0 (Q1 2025).